Top-News
  • Watchlist
  • Glocke
  • Handeln

    • SMI News

    12.067,24 -0,76% -92,885
    11.06.24 22:00:13 Ariva Indikation aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 969000
    ISIN: CH0009980894
    Typ: Index
    Weiter abwärts? Short handeln - Jetzt mit Hebel 5,05: VM2748

    Unternehmensmeldungen

    11.06.24 - DGAP
    Annual General Shareholders’ Meeting 2024: Sonova shareholders approve all motions of the Board of Directors
    Sonova Holding AG / Key word(s): AGMEGM Annual General Shareholders’ Meeting 2024: Sonova shareholders approve all motions of the Board of Directors 11.06.2024 / 18:04 ...
    11.06.24 - DGAP
    Ordentliche Generalversammlung 2024: Sonova Aktionäre stimmen allen Anträgen des Verwaltungsrates zu
    Sonova Holding AG / Schlagwort(e): Generalversammlung Ordentliche Generalversammlung 2024: Sonova Aktionäre stimmen allen Anträgen des Verwaltungsrates zu 11.06.2024 / ...
    11.06.24 - DGAP
    Partners Group closes its fifth direct private equity program with total commitments above its target of USD 15 billion
    Partners Group / Key word(s): Funds Partners Group closes its fifth direct private equity program with total commitments above its target of USD 15 billion 11.06.2024 / 07:00 CET/CEST
    05.06.24 - DGAP
    Holcim advances circular construction with acquisition of Land Recovery in the UK
    Holcim Group Services Ltd / Key word(s): Acquisition Holcim advances circular construction with acquisition of Land Recovery in the UK 05.06.2024 / 07:00 CET/CEST
    31.05.24 - GlobeNewswire
    Novartis Scemblix® Phase III data first to show superior efficacy with a favorable safety and tolerability profile vs. standard-of-care TKIs in adults with newly diagnosed CML
    Phase III ASC4FIRST trial met both primary endpoints with clinically meaningful and statistically significant results; Scemblix ® (asciminib) demonstrated superior MMR rates at ...
    31.05.24 - Businesswire
    UBS completes merger of UBS AG and Credit Suisse AG
    Regulatory News:
    31.05.24 - GlobeNewswire
    Novartis Phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria
    Patients treated with remibrutinib experienced improvements in weekly urticaria activity scores (UAS7) observed as early as Week 1 and sustained to 1 year (Week 52) 1 ...
    30.05.24 - Businesswire
    UBS announces changes to Group Executive Board
    Regulatory News:
    29.05.24 - DGAP
    Swiss Life publiziert die Betriebsrechnung 2023 zum BVG-Geschäft
    Swiss Life Holding AG / Schlagwort(e): Sonstiges Swiss Life publiziert die Betriebsrechnung 2023 zum BVG-​Geschäft 29.05.2024 / 07:00 CET/CEST
    27.05.24 - DGAP
    Life insurance set to boom as interest rates surge, says Swiss Re Institute
    Swiss Re Ltd / Key word(s): Research Update Life insurance set to boom as interest rates surge, says Swiss Re Institute 27.05.2024 / 10:00 CET/CEST
    27.05.24 - DGAP
    Swiss Re Institute sieht dank steigender Zinsen Boom bei Lebensversicherungen
    Swiss Re Ltd / Schlagwort(e): Research Update Swiss Re Institute sieht dank steigender Zinsen Boom bei Lebensversicherungen 27.05.2024 / 10:00 CET/CEST
    25.05.24 - GlobeNewswire
    Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio
    In the ALIGN study, atrasentan, in addition to supportive care with a renin-​angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in ...
    25.05.24 - GlobeNewswire
    Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo
    Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo 1 ; additional 6-month open-​label data to be ...
    22.05.24 - DGAP
    Partners Group announces results of the 2024 Annual General Meeting of Shareholders
    Partners Group / Key word(s): Miscellaneous Partners Group announces results of the 2024 Annual General Meeting of Shareholders 22.05.2024 / 19:30 CET/CEST
    16.05.24 - GlobeNewswire
    Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash
    Novartis secured 79.6 percent acceptance by MorphoSys shareholders during the initial acceptance period, reaching the minimum 65% acceptance threshold Settlement of the ...
    16.05.24 - DGAP
    Swiss Re announces changes to the Group Executive Committee
    Swiss Re Ltd / Key word(s): Personnel Swiss Re announces changes to the Group Executive Committee 16.05.2024 / 07:01 CET/CEST
    16.05.24 - DGAP
    Swiss Re gibt Änderungen im Group Executive Committee bekannt
    Swiss Re Ltd / Schlagwort(e): Personalie Swiss Re gibt Änderungen im Group Executive Committee bekannt 16.05.2024 / 07:01 CET/CEST
    16.05.24 - DGAP
    Holcim breaks ground of state-of-the-art GO4ZERO plant in Belgium for net-zero cement
    Holcim Group Services Ltd / Key word(s): Miscellaneous Holcim breaks ground of state-​of-the-art GO4ZERO plant in Belgium for net-zero cement 16.05.2024 / 07:00 CET/CEST
    15.05.24 - DGAP
    Aktionäre von Swiss Life genehmigen alle Anträge des Verwaltungsrats
    Swiss Life Holding AG / Schlagwort(e): Generalversammlung Aktionäre von Swiss Life genehmigen alle Anträge des Verwaltungsrats 15.05.2024 / 17:00 CET/CEST
    15.05.24 - DGAP
    Swiss Life shareholders approve all resolutions proposed by the Board of Directors
    Swiss Life Holding AG / Key word(s): AGMEGM Swiss Life shareholders approve all resolutions proposed by the Board of Directors 15.05.2024 / 17:00 CET/CEST

    Newssuche

    Videos

    10.06.24 +3,33%
    Technical Trading: Top Trade auf Zucker
    Sugar No.11 Long Typ: Turbo Open End WKN: VV50DP Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »